Dallas, Texas (PRWEB) March 29, 2014
The global POC diagnostics market is estimated to grow at a lower CAGR in developed countries; however, it is expected to witness high growth in emerging countries such as China, India, and Brazil. Factors such as rising prevalence of lifestyle and infectious diseases, increasing usage of home-based POC devices, technological advancements, and decreasing number of technicians in the central labs are propelling the growth of the POC diagnostics market. However, factors such as lack of alignment with definitive central lab methods, reluctance to change existing treatment practices and the recall of leading glucose monitoring devices are restraining the growth of this market.
Complete report is available at http://www.rnrmarketresearch.com/point-of-care-diagnostic-market-by-products-glucose-monitoring-infectious-diseases-testing-kits-cardiac-tumor-markers-by-end-users-self-professional-monitoring-over-the-counter-prescrip-market-report.html.
In this report, the global POC diagnostics market has been segmented on the basis of category (infectious diseases testing kits, glucose monitoring kits, cardiac markers, pregnancy and fertility testing kits, and others) and end users (patient professional monitoring kits and patient self-monitoring kits). The glucose monitoring kits market held the largest share—53.7%—of the global POC diagnostics market in 2013, followed by the infectious diseases testing kits market. Factors such as rising global prevalence of diabetes, technological advancements in self-monitoring of blood glucose, and the growing patient awareness toward POC testing are stimulating the growth of the glucose monitoring kits market.
The fastest-growing segment—cardiac-markers market—is projected to grow at a CAGR of 15.3% from 2013 to 2018. This growth is mainly attributed to the increasing number of cardiac patients and the demand of immediate diagnosis of the diseases. Major players such as Roche (Switzerland), Abbott Laboratories, Inc. (U.S.), Siemens AG (Germany), Beckman Coulter, Inc. (U.S.), and Alere Inc. (U.S.) are adopting several growth strategies such as new product launches, partnerships, agreements, collaborations, joint ventures, and mergers and acquisition in order to keep pace with the evolving industry trends.
Geographically, North America commands the largest share of the global POC diagnostics market in 2013, followed by Asia-Pacific. A number of factors such as increase in waiver of CLIA for certain point of care diagnostic tests, fostering FDA approvals for various immunoassay techniques, easy access to POC tests through diagnostic service providers, and presence of major leading companies are driving the growth of the POC diagnostics market in North America. However, the economic slowdown and unfavorable reimbursement scenario for tests due to government budget constraints the growth of the POC diagnostics market in this region. The Asia-Pacific region is poised to grow at the highest CAGR in the next five years. Factors such as huge patient population base, large number of R&D activities, and growing focus of both international and domestic players on the Asia-Pacific POC diagnostics market are propelling the growth of the dialysis market in the Asia-Pacific region.
The global POC diagnostics market is highly competitive with a large number of global as well as local market players. As of 2012, the global POC diagnostics market excluding the blood glucose monitoring kits market was dominated by Roche (Switzerland), Alere Inc. (U.S.), Siemens AG (Germany), and Beckman Coulter, Inc. (U.S.), which together accounted for ~72% of the market. New product launches and partnerships/agreements/collaborations/joint ventures are the major strategies adopted by most market players to achieve growth in the POC diagnostics market.
Order a copy of this report at http://www.rnrmarketresearch.com/contacts/purchase?rname=160445.
Reasons to Buy the Report:
From an insight perspective, this research report has focused on various levels of analysis—industry analysis (PEST analysis and Porter’s five force model), market share analysis of top players, value chain analysis, supply chain analysis, and company profiles, which together comprise and discuss the basic views on the competitive landscape, emerging and high growth segments of the POC diagnostics market, high-growth regions and countries and their respective regulatory policies, government initiatives, drivers, restraints, and opportunities. The above mentioned market research data, current market size, and forecast of future trends will help existing players and new entrants to make the necessary decisions regarding the product offerings, geographic focus, change in strategic approach, R&D investments for innovation in products and technologies, and levels of output in order to remain successful.
Companies purchasing the report could use any one or combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for reaping market share.
The report provides insights on the following pointers:
Major points from table of content
11 Company Profiles
11.1 Abaxis, Inc.
11.2 Abbott Laboratories, Inc.
11.3 Alere, Inc.
11.4 Bayer Healthcare ag (A Subsidiary Of Bayer ag)
11.5 Beckman Coulter, Inc. (A Subsidiary Of Danaher Corporation)
11.6 Becton, Dickinson And Company
11.7 Johnson & Johnson
11.8 Nipro Diagnostics, Inc. (A Subsidiary Of Nipro Corporation)
11.9 Roche Diagnostics Limited (A Subsidairy Of F. Hoffmann-La Roche Ltd)
11.1 Siemens Healthcare (A Division Of Siemens ag)
Browse more reports on Point of Care Diagnostics Market at http://www.rnrmarketresearch.com/reports/life-sciences/diagnostics/in-vitro-diagnostics-ivd/point-of-care-diagnostics.
RnRMarketResearch.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.